Lir Therapeutics is an AI-first viral vector company developing AAV gene-therapy vectors designed to reduce dosage, improve tissue targeting, and evade pre-existing immunity through AI modelling and lab-in-the-loop screening.
Lir Therapeutics is an AI-first viral vector company developing AAV gene-therapy vectors designed to reduce dosage, improve tissue targeting, and evade pre-existing immunity through AI modelling and lab-in-the-loop screening.